Nicholas Investment Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-106,119
| Closed | -$4.01M | – | 258 |
|
|
2018
Q2 | $4.01M | Buy |
106,119
+66,629
| +169% | +$2.52M | 0.28% | 115 |
|
|
2018
Q1 | $1.29M | Sell |
39,490
-15,683
| -28% | -$512K | 0.09% | 213 |
|
|
2017
Q4 | $2.69M | Sell |
55,173
-8,832
| -14% | -$430K | 0.18% | 177 |
|
|
2017
Q3 | $3.46M | Sell |
64,005
-27,170
| -30% | -$1.47M | 0.24% | 142 |
|
|
2017
Q2 | $5.12M | Sell |
91,175
-375
| -0.4% | -$21.1K | 0.36% | 82 |
|
|
2017
Q1 | $3.59M | Buy |
91,550
+67,537
| +281% | +$2.65M | 0.25% | 140 |
|
|
2016
Q4 | $539K | Buy |
+24,013
| New | +$539K | 0.04% | 262 |
|
|
2016
Q3 | – | Sell |
-59,904
| Closed | -$1.41M | – | 338 |
|
|
2016
Q2 | $1.41M | Buy |
59,904
+6,158
| +11% | +$145K | 0.1% | 275 |
|
|
2016
Q1 | $1.1M | Sell |
53,746
-35,845
| -40% | -$731K | 0.08% | 280 |
|
|
2015
Q4 | $4.61M | Buy |
89,591
+20,884
| +30% | +$1.07M | 0.32% | 120 |
|
|
2015
Q3 | $2.93M | Buy |
68,707
+21,150
| +44% | +$901K | 0.21% | 201 |
|
|
2015
Q2 | $2.17M | Sell |
47,557
-15,184
| -24% | -$692K | 0.14% | 256 |
|
|
2015
Q1 | $2.38M | Buy |
62,741
+7,115
| +13% | +$270K | 0.15% | 245 |
|
|
2014
Q4 | $1.58M | Buy |
+55,626
| New | +$1.58M | 0.1% | 268 |
|